Furthermore, in recent biomarker studies of the VEGF family, serum levels of VEGF-D were found to be significantly elevated in patients with sporadic or TSC-associated LAM as compared with healthy controls and patients with other pulmonary illnesses [31,32]. The gene discussed is VEGFA; the disease is lymphangioleiomyomatosis.